首页> Journal of clinical oncology : official journal of the American Society of Clinical Oncology> Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.

导出 OA

翻译打印收藏纠错

第一作者： James N,Kochenderfer

第一单位： James N. Kochenderfer, Robert P.T. Somerville, Tangying Lu, Victoria Shi, Stephanie L. Goff, James C. Yang, Richard M. Sherry, Christopher A. Klebanoff, Udai S. Kammula, Constance M. Yuan, Mark J. Roschewski, Steven A. Feldman, Lori McIntyre, Mary Ann Toomey, and Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD; Adrian Bot, John Rossi, Allen Xue, Marika Sherman, and Arianne Perez, Kite Pharma, Santa Monica, CA; Tatyana Feldman, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; and Jonathan W. Friedberg, University of Rochester School of Medicine, Rochester, NY.

作者： James N,Kochenderfer ^[1] ; Robert P T,Somerville ^[1] ; Tangying,Lu ^[1] ; Victoria,Shi ^[1] ; Adrian,Bot ^[1] ; John,Rossi ^[1] ; Allen,Xue ^[1] ; Stephanie L,Goff ^[1] ; James C,Yang ^[1] ; Richard M,Sherry ^[1] ; Christopher A,Klebanoff ^[1] ; Udai S,Kammula ^[1] ; Marika,Sherman ^[1] ; Arianne,Perez ^[1] ; Constance M,Yuan ^[1] ; Tatyana,Feldman ^[1] ; Jonathan W,Friedberg ^[1] ; Mark J,Roschewski ^[1] ; Steven A,Feldman ^[1] ; Lori,McIntyre ^[1] ; Mary Ann,Toomey ^[1] ; Steven A,Rosenberg ^[1]

作者单位： James N. Kochenderfer, Robert P.T. Somerville, Tangying Lu, Victoria Shi, Stephanie L. Goff, James C. Yang, Richard M. Sherry, Christopher A. Klebanoff, Udai S. Kammula, Constance M. Yuan, Mark J. Roschewski, Steven A. Feldman, Lori McIntyre, Mary Ann Toomey, and Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD; Adrian Bot, John Rossi, Allen Xue, Marika Sherman, and Arianne Perez, Kite Pharma, Santa Monica, CA; Tatyana Feldman, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; and Jonathan W. Friedberg, University of Rochester School of Medicine, Rochester, NY. ^[1]